Survivors of childhood central nervous system cancer show affected self-identity
the ONA take:
According to a new study published in the journal Neuro-Oncology, researchers from the Korlinska Institutet in Sweden have found that patients treated for central nervous system (CNS) cancer during childhood or adolescence can display altered self-perception and self-identify later in adulthood.
For the study, researchers followed 700 adult survivors of childhood CNS cancer who were diagnosed between 1992 and 2001. Researchers compared these patients to a control group from the general population. They studied how the cancer, the treatment, and the aftermath affected the patient's health, function, and psychological identity. Psychological identity includes their self-perception and self-esteem, which researchers assessed using a standardized self-report questionnaire.
Results showed that all components of having CNS cancer affected patients' psychological identity later in adulthood. Researchers found survivors more often had a negative self-perception compared with the control group.
For example, in the context of work and friends, 22% and 30% of survivors had a negative self-perception, respectively, while 8% and 17% of the control group had a negative self-perception, respectively.
Results of self-perception were similar across both groups in the context of family. Findings suggest that more preventative measures are necessary to aid in long-term personality development.
Patients treated for CNS cancer during childhood can display altered self-perception later in adulthood.
The study followed 700 adult survivors diagnosed 1992-2001 with a childhood CNS tumour. The study group covered all adult brain tumour survivors in Sweden at the time of start of study. Patients were compared with a control group selected from the general population.
- Physical Activity Improves Outcomes for Patients with Breast Cancer and Survivors
- Behavior Pain Assessment Tool Measures Pain In Patients Who Cannot Communicate Verbally
- Whole Genome Sequencing Reveals that 12% of Childhood Cancer Survivors Have Mutations in Genes that Increase Cancer Risk
- Increased 5-Year Survival Rate Seen in NSCLC Subset Treated With Nivolumab
- Novel Test For Multiple Myeloma Uses Microchip, Conventional Blood Sample
- Exercise, Psychological Interventions Better for Cancer Fatigue Than Medications
- ASCO Issues Global Guidance for HPV Vaccination for Cervical Cancer Prevention
- Discharge Events Improved With Standardized Inpatient Palliative Care Consultation
- Little Opposition to Early Palliative Care for Symptom Management in Pediatric Oncology
- Updated ASTRO Guideline Bolsters Safety, Efficacy of Palliative RT for Bone Metastases
- Thyroid Cancer Incidence Increasing Among Younger, Hispanic, African American Populations
- JAK1, JAK2 Inhibition Improves Outcomes in Myeloproliferative Neoplasms, But More Is Needed
- Recommendations Against Contralateral Prophylactic Mastectomy Not Tied to Patient Satisfaction
- Self-efficacy Level Predictive of Likelihood to Follow Through With Colorectal Cancer Screening
- Chronic Myeloproliferative Neoplasms Treatment (Fact Sheet)
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|